市場調查報告書

抗體產生的全球市場:各類型、各流程、各最終用途、各地區 - 市場分析,規模,佔有率,趨勢,預測 (2021∼2027年)

Antibody Production Market, By Type, By Process, By End-Use, and By Geography - Analysis, Size, Share, Trends, & Forecast from 2021-2027

出版商 AnalystView Market Insights 商品編碼 950979
出版日期 內容資訊 英文 220 Pages
商品交期: 2-3個工作天內
價格
抗體產生的全球市場:各類型、各流程、各最終用途、各地區 - 市場分析,規模,佔有率,趨勢,預測 (2021∼2027年) Antibody Production Market, By Type, By Process, By End-Use, and By Geography - Analysis, Size, Share, Trends, & Forecast from 2021-2027
出版日期: 2020年07月01日內容資訊: 英文 220 Pages
簡介

全球抗體產生的市場規模,預計2019年達到102億7000萬美元,2021∼2027年間更將以15.1%的年複合成長率成長。各國政府的研究支援,新型冠狀病毒感染疾病 (COVID-19) 等感染疾病的風險增加,強力推動市場成長。

本報告提供全球抗體產生的市場調查分析,市場定義和基本結構,主要的推動及阻礙市場要素,產業的競爭力、向心力,市場佔有率結構,各類型、各流程、各最終用途、各地區的市場趨勢預測 (過去5年、今後7年份),主要企業的簡介等相關調查。

第1章 抗體產生市場概要

第2章 摘要整理

第3章 抗體產生:主要的市場趨勢

  • 推動市場要素
    • 推動市場要素的影響度分析
  • 阻礙市場要素
    • 阻礙市場要素的影響度分析
  • 市場機會
  • 未來市場趨勢

第4章 抗體產生:產業研究

  • 波特的五力分析
  • 行銷策略分析
  • 市場成長預測:製圖
  • 管理體制分析

第5章 抗體產生市場:COVID-19的影響分析

  • Covid-19前的影響分析
  • Covid-19後的影響分析
    • 大幅度成長的市場區隔
    • 一定成長的市場區隔
    • 大幅度縮小的市場區隔
    • 一定縮小的市場區隔

第6章 抗體產生:市場環境

  • 市場佔有率分析
  • 主要的技術創新企業 (創新者)
  • 市場區隔資料:各主要製造商
    • 現有企業分析
    • 新企業分析

第7章 抗體產生市場:各生產品

  • 概要
  • 多株抗體
  • 單株抗體

第8章 抗體產生市場:各流程

  • 概要
  • 上游處理
  • 過濾
  • 下游處理

第9章 抗體產生市場:各最終用途

  • 概要
  • 製藥/生物科技企業
  • 研究機關
  • 診斷檢驗室

第10章 抗體產生市場:各地區

  • 簡介
    • 市場佔有率分析:各地區 (2020年,2027年)
  • 北美市場
    • 概要
    • 域內的主要製造商
    • 市場規模與其預測:各國 (以金額為準,2015∼2026年)
    • 市場規模與其預測:各生產品 (以金額為準,2015∼2026年)
    • 市場規模與其預測:各流程 (以金額為準,2015∼2026年)
    • 市場規模與其預測:各最終用途 (以金額為準,2015∼2026年)
    • 美國
    • 加拿大
  • 歐洲市場
    • 德國
    • 義大利
    • 英國
    • 法國
    • 其他歐洲各國
  • 亞太地區 (APAC) 市場
    • 印度
    • 中國
    • 日本
    • 韓國
    • 其他的亞太地區各國
  • 南美市場
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他的南美各國
  • 中東、非洲市場
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國 (UAE)

第11章 供應商分析

  • Competitive Dashboard
  • Company Profiles
  • Eppendorf AG
  • FiberCell Systems Inc.
  • Merck KGaA
  • INTEGRA Biosciences AG
  • Cellab GmbH
  • Pall Corp.
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.

第12章 分析師全方位展望

第13章 附錄

目錄

Title:
Antibody Production Market, By Type (Polyclonal Antibody and Monoclonal Antibody), By Process (Upstream Processing [Bioreactors and Consumables], Downstream Processing [Chromatography Systems and Chromatography Resins], Filtration [Filtration Systems and Filtration Consumables and Accessories]), By End-Use (Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories and Research Institutes), and By Geography (EU, NA, APAC, LATAM, and MEA) - Analysis, Size, Share, Trends, & Forecast from 2021-2027.

REPORT HIGHLIGHT

The global antibody production market was valued at USD 10.27 billion by 2019, growing with 15.1% CAGR during the forecast period, 2021-2027.

The National Human Genome Research Institutes (NHGRI) defined antibody as a protein component of the immune system, whose function comprises of blood circulation, recognition of the foreign substance like bacteria and virus in the blood, and neutralize them. After the exposure of foreign substances, so-called antigens, antibodies get activated, continue their circulation in bodies, and protect the host from future antigens.

Antibodies play an essential role in treating several health conditions, including rheumatoid arthritis, cancers, psoriasis, multiple sclerosis, etc. Antibody production refers to the creation of a specific antibody, involving numerous steps, like immunogen preparation, immunization, hybridoma creation, collection, screening, isotyping, purification, and labeling. The production of antibodies can be done in the host animal and through additional procedures in the laboratories.

MARKET DYNAMICS

Antibody production is widely adopted in the medical industry for research and development purposes. Thus, the growing demand for therapeutic antibodies, the adoption of targeted therapy, and the U.S. FDA clearance of therapeutic mAbs are the key determiners responsible for the global antibody production market growth. The demand for the production of antibodies is also influenced by the increasing prevalence of chronic diseases such as cancer, rheumatic heart disease, and arthritis; as these conditions can be treated with antibodies. As per the data revealed by the American Cancer Society (ACS), in 2019, in the US only, the estimated number of newly diagnosed cancer cases reached 1,762,450, whereas the death count was 606,880.

Furthermore, the rising risk of infectious disease, like COVID-19, and the escalating demand for protein therapeutics are responsible for elevating the market potential. As per the data updated by the World Health Organization (WHO), the count of coronavirus infected patient's cases was 12,964,809; whereas the number of deaths was recorded more than 570,000, as of mid-July 2020. On the contrary, the key global antibody production market restraints account for the high cost of the primary antibodies, which will hamper the demand during the forecast period.

Type Takeaway

The type segment is bifurcated into polyclonal and monoclonal antibody. The monoclonal antibody segment is further divided into Murine, Chimeric, and Humanized. This segment is estimated to have the maximum market share during the upcoming decade, accounting for the increasing investment by key players for the development of such antibodies along with the high product demand for the treatment of chronic diseases.

Flip-side, the polyclonal antibody segment witnesses a fast growth rate in the near future. The demand for the polyclonal antibody is predominately influenced by the growing demand for therapeutic antibodies, and the intensifying R&D investments. For instance, in July 2020, Massachusetts based biotechnology company, Revitope Oncology Inc. Oncology Inc. collaborated with Shanghai Junshi Biosciences Co. Ltd. to develop antibody-based immune therapies for cancer. As per the collaboration, both the companies will explore next-generation immunotherapies with precision-targeted T-cell engaging antibodies.

Process Takeaway

Based on the process, the industry is fragmented into upstream processing, downstream processing, and filtration process. The upstream processing is further divided into consumables and bioreactors. The bioreactors sub-segment includes large-scale bioreactors and single-use bioreactors; whereas the consumables sub-segment comprises of media & buffers and reagents. Switching back to the downstream processing segment, this process is broadly categorized into chromatography and chromatography resins. Lastly, the filtration segment includes filtration systems and filtration accessories and consumables.

The downstream processing segment dominates the market and is likely to grow at the same pace in the study period, followed by upstream processing. Factors impacting the demand include the commercial success of biopharmaceuticals products that further aids in boosting the demand for innovation in bioprocessing along with the application of accurate and efficient products including chromatography instruments and resins. Besides, the increasing investment in production infrastructure by manufacturers is responsible for propelling the growth of the upstream process. Nevertheless, the usage of advanced bioreactors and filters is likely to influence the filtration process segment in the future.

End-Use Takeaway

Depending upon end-users, the industry is categorized into pharmaceutical & biotechnology companies, research institutes, and diagnostic laboratories. The pharmaceutical and biotechnology segment is taking deep dive into the biotechnology industry, which is anticipated to offer potential growth and development in the global market. Increasing research and development spending by key vendors along with the expanding count of strategic collaborations among companies support the segment growth.

For instance, in June 2020, GlaxoSmithKline collaborated with U.S. based biotech firm, Vir Biotechnology. As a part of the partnership, GSK is likely to invest US$250 million for R&D activities that are designed to advance COVID-19 candidates into Phase II clinical trials.

REGIONAL TAKEAWA

Regionally, the overall market is divided into North America, Middle East & Africa, Asia Pacific, Latin America, and Europe. In 2019, North America has registered the majority of share followed by Europe and the Asia Pacific. Increasing government expenditure for new product development, presence of key players, and the rising cases of cancer are the key determiners supporting the growth of North America's antibody production market potential. Strong growth industry players such as GE Healthcare, Thermo Fisher Scientific, Inc., Pall Corporation, and FiberCell Systems Inc. are supporting these reginal growths. Contrary, the Asia Pacific is anticipated to be the fastest-growing region throughout the forecast owing to the untapped opportunities available in this region coupled with the developing healthcare infrastructure.

COVID-19 IMPACT

The sudden outbreak of the coronavirus, as an infectious disease, has positively influenced the growth of the antibody production market. The demand for a cure, capable of treating COVID, is increasing exponentially concerning the growing confirmed cases per day. The demand for antibodies is predominately influenced by rising investments by many companies in the search for the cure via the production of antibodies. For instance, in April 2020, Astra Zeneca collaborated with the government and academia for the discovery of novel coronavirus-neutralizing antibodies.

KEY VENDOR TAKEAWA

The leading players of the global antibody production market include Eppendorf AG, Cellab GmbH, FiberCell Systems Inc., GE Healthcare, Merck KGaA, INTEGRA Biosciences, Sartorius AG, Thermo Fisher Scientific, and Pall Corporation.

Key players are continuously making efforts to enhance their business portfolio via new product developments, research collaborations, investments in the development of vaccines, etc. Such developments may account for the Thermo Fisher Scientific Inc. collaboration with WuXi Diagnostics and Mayo Clinic in May 2020. According to the collaboration, Thermo Fisher expanded its product portfolio with the development of a total antibodies test to combat COVID-19. The test is designed to run on an open instrument platform, and the determination of antibody status will aid in the diagnosis of the disease during the acute and recovery stages of infection.

The market size and forecast for each segment and sub-segments has been considered as below:

Historical Year - 2016 to 2018

Base Year - 2019

Estimated Year - 2020

Projected Year - 2021 to 2027

TARGET AUDIENCE

Traders, Distributors, and Suppliers

Manufacturers

Government and Regional Agencies

Research Organizations

Consultants

Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTIBODY PRODUCTION MARKET KEY PLAYERS

Cellab GmbH

Eppendorf AG

FiberCell Systems Inc.

GE Healthcare

INTEGRA Biosciences AG

Merck KGaA

Pall Corp.

Sartorius AG

Thermo Fisher Scientific, Inc.

GLOBAL ANTIBODY PRODUCTION MARKET, BY PRODUCTION

Monoclonal antibody

Chimeric

Murine

Humanized

Polyclonal antibody

GLOBAL ANTIBODY PRODUCTION MARKET, BY PROCESS

Upstream Processing

Consumables

Media

Buffers And Reagents

Bioreactors

Large-Scale Bioreactors

Single-Use Bioreactors

Downstream Processing

Chromatography Resins

Chromatography Systems

Filtration

Filtration Systems

Filtration Consumables and Accessories

GLOBAL ANTIBODY PRODUCTION MARKET, BY END-USE

Pharmaceutical and Biotechnology Companies

Research Institutes

Diagnostic Laboratories

Others

GLOBAL ANTIBODY PRODUCTION MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Singapore

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

The Middle East and Africa

Saudi Arabia

United Arab Emirates

Rest of MEA

TABLE OF CONTENT

1. ANTIBODY PRODUCTION MARKET OVERVIEW

  • 1.1. Study Scope

2. EXECUTIVE SUMMARY

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Production
    • 2.1.2. Market Snippet by Process
    • 2.1.3. Market Snippet by End-Use
    • 2.1.4. Market Snippet by Region
  • 2.2. Competitive Insights

3. ANTIBODY PRODUCTION KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. ANTIBODY PRODUCTION INDUSTRY STUDY

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. ANTIBODY PRODUCTION MARKET: COVID-19 IMPACT ANALYSIS

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. ANTIBODY PRODUCTION MARKET LANDSCAPE

  • 6.1. Market Share Analysis, 2019
  • 6.2. Key Innovators Analysis
  • 6.3. Breakdown Data, by Key Manufacturer
    • 6.3.1. Established Players' Analysis
    • 6.3.2. Emerging Players' Analysis

7. ANTIBODY PRODUCTION MARKET - BY PRODUCTION

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Production, 2020 & 2027 (%)
  • 7.2. Polyclonal antibody
    • 7.2.1. Overview
    • 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • 7.3. Monoclonal antibody
    • 7.3.1. Murine
      • 7.3.1.1. Overview
      • 7.3.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 7.3.2. Chimeric
      • 7.3.2.1. Overview
      • 7.3.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 7.3.3. Humanized
      • 7.3.3.1. Overview
      • 7.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

8. ANTIBODY PRODUCTION MARKET - BY PROCESS

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Process, 2020 & 2027 (%)
  • 8.2. Upstream processing
    • 8.2.1. Bioreactors
      • 8.2.1.1. Large-scale bioreactors
      • 8.2.1.1.1. Overview
      • 8.2.1.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 8.2.1.2. Single-use bioreactors
      • 8.2.1.2.1. Overview
      • 8.2.1.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 8.2.2. Consumables
      • 8.2.2.1. Media
      • 8.2.2.1.1. Overview
      • 8.2.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 8.2.2.2. Buffers and Reagents
      • 8.2.2.2.1. Overview
      • 8.2.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • 8.3. Filtration
    • 8.3.1. Filtration Systems
      • 8.3.1.1. Overview
      • 8.3.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 8.3.2. Filtration Consumables and Accessories
      • 8.3.2.1. Overview
      • 8.3.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • 8.4. Downstream processing
    • 8.4.1. Chromatography Systems
      • 8.4.1.1. Overview
      • 8.4.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 8.4.2. Chromatography Resins
      • 8.4.2.1. Overview
      • 8.4.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

9. ANTIBODY PRODUCTION MARKET - BY END-USE

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-Use, 2020 & 2027 (%)
  • 9.2. Pharmaceutical and Biotechnology Companies
    • 9.2.1. Overview
    • 9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • 9.3. Research Institutes
    • 9.3.1. Overview
    • 9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • 9.4. Diagnostic Laboratories
    • 9.4.1. Overview
    • 9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

10. ANTIBODY PRODUCTION MARKET- BY GEOGRAPHY

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2020 & 2027 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Production, 2016 - 2027 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Process, 2016 - 2027 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Production, 2016 - 2027 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Process, 2016 - 2027 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 10.3.11. Rest of Europe
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Key Manufacturers in the Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Production, 2016 - 2027 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Process, 2016 - 2027 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 10.4.11. Rest of APAC
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Production, 2016 - 2027 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Process, 2016 - 2027 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 10.5.10. Rest of LATAM
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Productions, 2016 - 2027 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Process, 2016 - 2027 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

11. KEY VENDOR ANALYSIS

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. GE Healthcare
      • 11.2.1.1. Company Snapshot
      • 11.2.1.2. Financial Performance
      • 11.2.1.3. Product Benchmarking
      • 11.2.1.4. Strategic Initiatives
  • 11.3. Eppendorf AG
  • 11.4. FiberCell Systems Inc.
  • 11.5. Merck KGaA
  • 11.6. INTEGRA Biosciences AG
  • 11.7. Cellab GmbH
  • 11.8. Pall Corp.
  • 11.9. Sartorius AG
  • 11.10. Thermo Fisher Scientific, Inc.

12. 360 DEGREE ANALYSTVIEW

13. APPENDIX

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Antibody production market: Productions Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Productions
  • TABLE Global antibody production market, by Productions 2016-2027 (USD Million)
  • TABLE Antibody production market: Process Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Process
  • TABLE Global antibody production market, by Process 2016-2027 (USD Million)
  • TABLE Antibody production market: End-Use Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by End-Use
  • TABLE Global antibody production market, by End-Use 2016-2027 (USD Million)
  • TABLE Antibody production market: Regional snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global antibody production market, by Region 2016-2027 (USD Million)
  • TABLE North America antibody production market, by Country, 2016-2027 (USD Million)
  • TABLE North America antibody production market, by Productions, 2016-2027 (USD Million)
  • TABLE North America antibody production market, by Process, 2016-2027 (USD Million)
  • TABLE North America antibody production market, by End-Use, 2016-2027 (USD Million)
  • TABLE Europe antibody production market, by Country, 2016-2027 (USD Million)
  • TABLE Europe antibody production market, by Productions, 2016-2027 (USD Million)
  • TABLE Europe antibody production market, by Process, 2016-2027 (USD Million)
  • TABLE Europe antibody production market, by End-Use, 2016-2027 (USD Million)
  • TABLE Asia Pacific antibody production market, by Country, 2016-2027 (USD Million)
  • TABLE Asia Pacific antibody production market, by Productions, 2016-2027 (USD Million)
  • TABLE Asia Pacific antibody production market, by Process, 2016-2027 (USD Million)
  • TABLE Asia Pacific antibody production market, by End-Use, 2016-2027 (USD Million)
  • TABLE Latin America antibody production market, by Country, 2016-2027 (USD Million)
  • TABLE Latin America antibody production market, by Production, 2016-2027 (USD Million)
  • TABLE Latin America antibody production market, by Process, 2016-2027 (USD Million)
  • TABLE Latin America antibody production market, by End-Use, 2016-2027 (USD Million)
  • TABLE Middle East and Africa antibody production market, by Country, 2016-2027 (USD Million)
  • TABLE Middle East and Africa antibody production market, by Production, 2016-2027 (USD Million)
  • TABLE Middle East and Africa antibody production market, by Process, 2016-2027 (USD Million)
  • TABLE Middle East and Africa antibody production market, by End-Use, 2016-2027 (USD Million)

List of Figures

  • FIGURE Antibody production market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2019
  • FIGURE Production segment market share analysis, 2020 & 2027
  • FIGURE Production segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Polyclonal antibody market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Murine market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Chimeric market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Humanized market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Process segment market share analysis, 2020 & 2027
  • FIGURE Process segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Large-scale bioreactors market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Single-use bioreactors market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Media market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Buffers and reagents market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Chromatography systems market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Chromatography resins market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Filtration systems market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Filtration consumables and accessories market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE End-Use segment market share analysis, 2020 & 2027
  • FIGURE End-Use segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Pharmaceutical and biotechnology companies market size forecast and trend analysis, 2016 to 2027 (USD Million)

FIGUREResearch laboratories market size forecast and trend analysis, 2016 to 2027 (USD Million)

FIGUREOthersmarket size forecast and trend analysis, 2016 to 2027 (USD Million)

  • FIGURE Regional segment market share analysis, 2020 & 2027
  • FIGURE Regional segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE North America antibody production market share and leading players, 2019
  • FIGURE Europe antibody production market share and leading players, 2019
  • FIGURE Asia Pacific antibody production market share and leading players, 2019
  • FIGURE Latin America antibody production market share and leading players, 2019
  • FIGURE Middle East and Africa antibody production market share and leading players, 2019
  • FIGURE North America market share analysis by country, 2019
  • FIGURE U.S. antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Canada antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Europe antibody production market share analysis by country, 2019
  • FIGURE Germany antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Spain antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Italy antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE UK antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE France antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of the Europe antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Asia Pacific antibody production market share analysis by country, 2019
  • FIGURE India antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE China antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Japan antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE South Korea antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Singapore antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of APAC antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America antibody production market share analysis by country, 2019
  • FIGURE Brazil antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Mexico antibody production market size, forecast, and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Argentina antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of LATAM antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa antibody production market share analysis by country, 2019
  • FIGURE Saudi Arabia antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE United Arab Emirates antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)